Hepatoprotective effect of Chichorium intybus L. on liver toxicity in rat

Journal of Medicinal Plants

Volumn 5, Issue 17, 2006, Pages 32-38

  Madani, H ^a   Asgary, S ^b   Naderi, G H ^b   Talebolhoseini, M ^a  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Chichorium intybus; Hepatoprotective; Polyphenolic compounds; Silybum marianum; Thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHICHORIUM INTYBUS EXTRACT; PLANT EXTRACT; POLYPHENOL DERIVATIVE; POTASSIUM; SILYBUM MARIANUM EXTRACT; SODIUM; THIOACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHICHORIUM INTYBUS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; ENZYME ACTIVITY; LIVER PROTECTION; LIVER TOXICITY; MEDICINAL PLANT; NONHUMAN; RAT; SILYBUM MARIANUM;

CICHORIUM INTYBUS; SILYBUM MARIANUM;

EID: 33746861976     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Germano MP, Sanogo R and Costa C. Hepatoprotective properties in the rat of Mitracarpus scaber (rubiaceae). J. Pharm. Pharmacol. 1999; 51: 729-734.
2. Carreon JP, Iimenez GC and Vega JL. Genotoxic and antigenotoxic properties of Calendula officinalis extracts in rat liver cell cultures treated with diethylnitrosamine. Toxicology in vitro. 2002; 16: 235-258.
3. Chattopadhyay RR. Possible mechanism of hepatoprotective activity of Azadirachta indica leaf extract: Part II. J. Ethnopharmacology. 2003; 62: 31-39.
4. Yoshikava M, Xu F, Morikava T, Ninomya K and Matsuda H. Anaststins A and B, new skeletal flavonoids with hepatoprotective activities from the desert plant Anastatica hierochuntica. Bioorganic & Medicinal chemistry Letters. 2003; 13: 1045-1049.
5. 4-induced hepatotoxicity in rodents. Fitoterapia. 2002; 73: 557-564.
6. Sakihama Y, Cohen MF, Grace SC and Yamasaki H. Plant phenolic antioxidant and prooxidant activities: phenolics-induced oxidative damage mediated by metals in plants. Toxicology. 2002; 177: 67-80.
7. Pyo YH, Lee TC, Logendra L and Rosen RT. Antioxidant activity and phenolic compounds of Swiss chard (Beta vulgaris subspecies cycla) extracts. Food Chemistry. 2004; 85: 19-26.
8. Leng-Peschlow E and madause AG. Properties and medical use of flavonolignans from Sylibum marianum. Phytotherapy Res. 1996; 1: 25-26.
9. Favari L and Perez-Alvarez V. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats. Arch. Med. Res. 1997; 28, 11-17.
10. Schonfeld, JV, Weisbrod B and Muller MK. Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cycloporin A toxicity. Cellular and Molecular Life Sciences. 1997; 53: 917-920.
11. Schuppan D, Jia JD, Brinkhaus B and Hahn EG. Herbal products for liver diseases. Hepatology. 1999; 30, 1099-1104.
12. Jia JD and et al Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by down regulation of procollagen α1 (I) and TIMP-1. J. Hepatology. 2001; 35: 392-398.
13. Kalantari H and Rastmanesh M. Protective property of Cichorium intybus in CCl4 induced liver damage in mice. pearl.surns.ac.ir/Aim/0031/Kalantari0031. html. (2003).
14. Zafar R and Mujahid AS. Anti-hepatotoxic effects of root and root callus extracts of Cichorium intybus L. J. Ethnopharmacology. 1998; 63: 227-231.
15. Jeong TC and et al. Pretreatment of male BALB/c mice β-ionone potentiates thioacetamide-induced hepatotoxicity. Toxicology Letters. 1999; 105: 39-46.
16. Sallie R, Tredger JM and William R. Drug and the liver. Biopharmaeutical Drug Disposition. 1991; 12: 251-259.
17. Mitra SK, Venkataranganna MV, Sundaram R and Gopumadhavan S. Protective effect of HD-03, a herbal formulatin, against various hepatotoxic agents in rats. J. Ethnopharmacology. 1998; 63: 181-186.
18. Bruck R, Shirin H, Aeed H and Matas Z. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J. Hepatology. 2001; 35: 457-464.
19. Zaragoza A, Andres D, Sarrion D and Cascales M. Potentiation of thioacetamide hepatotoxicity by phenobarbital pretreatment in rats, inducibility of FAD monooxygenase system and age effect. Chemico-Biological Interactions. 2000; 124: 87-101.
20. Kim KH, Bae JH, Cha SW and Han SS. Role of metabolic activation by cytochorome P450 in thioacetamide-induced suppression of antibody response in male BALB/C mice. Toxicology Letters. 2000; 114: 225-235.
21. Amad A, Pillai KK, Najmi AK and Pal SN. Evaluation of hepatoprotective potential of jigrine post-treatment against thioacetamide induced hepatic damage. J. Ethnopharmacology. 2002; 79, 35-41.
22. Sanz N, Fernandez CD, Simon LF, Alvarez A and Cascales M. Necrogenic and regenerative responses of liver newly weaned rats against a sublethal dose of thioacetamide. Biochemica et Biophysica Acta. 1998; 1384: 66-78.
23. Tandon A, Tandon BN and Bhujwala RA. Clinical spectrum of acute sporadic hepatitis E and Possible benefit of glycyrrhizin therapy. Hepatology Res. 2002; 23: 55-61.
24. Baer-Dubowska W, Szaefer H and Krajka-Kuzniak V. Inhibition of murin hepatic cytochrom P450 activities by natural and synthetic phenolic compounds. Xenobiotica. 1998; 28: 735-743.
25. Zix MH and Agarwal R. Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin. Biochm. Biophys. Res. Commun. 1997; 239: 334-339.